Furthermore, multiple studies have confirmed that various CAF subsets, including POSTN+ CAFs, COL11A1+ CAFs, FAP+αSMA+ CAFs, and MYH11+αSMA+ CAFs, play critical roles in mediating ICI resistance in NSCLC patients (29, 53, 128). Here, ACTA1 is linked to non-small cell lung carcinoma.